|
WO2021016089A1
|
|
Methods for detecting hereditary cancers
|
|
WO2020263696A1
|
|
System and method to store and dispense immunoassay
|
|
WO2020243503A1
|
|
Determination of antidepressants by mass spectrometry
|
|
WO2020243108A1
|
|
Systems and methods to identify mutations in mitochondrial genomes
|
|
WO2020231774A1
|
|
MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS
|
|
WO2020160317A1
|
|
Methods for detecting legionella
|
|
WO2020081648A1
|
|
Genomic sequencing selection system
|
|
WO2020041512A1
|
|
Plate for sampling apparatus and microcentrifuge vial for microsampling apparatus
|
|
CA3110444A1
|
|
Microsampling detection in diabetes
|
|
CA3094080A1
|
|
Methods for detecting chromogranin a by mass spectrometry
|
|
CA3094088A1
|
|
Mass spectrometric determination of testosterone in multiplexed patient samples
|
|
US2020319140A1
|
|
Automated analysis of analytical gels and blots
|
|
US2019170711A1
|
|
Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry
|
|
CN111148998A
|
|
Apolipoprotein E isoform detection by mass spectrometry
|
|
CN110914691A
|
|
Method for quantifying insulin and C-peptide
|
|
MX2019008320A
|
|
Method for non-invasive prenatal screening for aneuploidy.
|
|
CA3048859A1
|
|
Compositions and methods for detecting circulating tumor dna
|
|
CN110168100A
|
|
The method for extracting detection Cystic Fibrosis mutations using the tip MITRA
|
|
US2018136211A1
|
|
Methods and devices for detecting hepatitis c virus
|
|
US2018135135A1
|
|
Methods for detecting dna mutations using mitra tip extraction
|
